Why Novocure stock is up today? By Investing.com

© Reuters. Why Novocure inventory is up at this time?

NovoCure (NASDAQ:) skilled a notable improve in its inventory worth, leaping up round 13% intra-day at this time, marking its highest level since Oct 19. This enhance is attributed to Novocure’s affirmation of its attendance on the upcoming JPMorgan healthcare investor convention subsequent month. William Doyle, the Govt Chairman of Novocure, is scheduled to current on behalf of the corporate on Jan 10.

Earlier this month, Piper Sandler highlighted Novocure as one of many firms anticipated to share insights into their fourth-quarter efficiency at this annual well being occasion. This expectation stems from Novocure’s historical past of offering such particulars in earlier years.

Novocure, the maker of a wearable cancer-targeting remedy referred to as TTFields, introduced final month a workforce discount of 13%. Regardless of this, the corporate maintains its readiness for the potential approval of its remedy for metastatic non-small cell lung most cancers after development on or after platinum-based therapies.